01—Abstract
Summary
Summary of the 8-K filed June 24, 2025. Cited figures are marked; the original filing is the authoritative source.
Keurig Dr Pepper Inc. (KDP) filed this Current Report on Form 8-K under Item 7.01 (Regulation FD Disclosure) in connection with meetings with members of the investment community held on June 23–24, 2025.
In these meetings, the Company reaffirmed its previously announced 2025 guidance. The reaffirmed guidance calls for constant currency net sales growth in a mid-single-digit range and Adjusted diluted EPS growth in a high-single-digit range for 2025.
The Company states that it provides guidance only on a non-GAAP basis and does not reconcile forward-looking non-GAAP measures to GAAP, citing the inability to predict the amount and timing of certain items such as non-cash mark-to-market gains or losses on derivatives, which could be material. The filing contains no new financial results or figures beyond the reaffirmation itself, and the information is furnished rather than filed for purposes of Section 18 of the Exchange Act.
02—Key points
Key Highlights
- Keurig Dr Pepper reaffirmed its previously announced 2025 guidance during investor meetings held June 23–24, 2025.
- Guidance calls for constant currency net sales growth in a mid-single-digit range for 2025.
- Guidance calls for Adjusted diluted EPS growth in a high-single-digit range for 2025.
- The reaffirmation is a Regulation FD disclosure under Item 7.01 and no new financial results are reported.
- Guidance is provided only on a non-GAAP basis; the Company does not reconcile forward-looking non-GAAP measures to GAAP.
- The Company cites unpredictable non-cash mark-to-market adjustments on derivative instruments as the reason it does not provide GAAP reconciliations, noting these could be material.
- The information is furnished, not filed, for purposes of Section 18 of the Exchange Act unless specifically stated otherwise.
03—Questions
Frequently Asked Questions
What did Keurig Dr Pepper reaffirm in this filing?
The Company reaffirmed its previously announced 2025 guidance: constant currency net sales growth in a mid-single-digit range and Adjusted diluted EPS growth in a high-single-digit range.
Why was this information disclosed?
The disclosure was made in connection with meetings with members of the investment community held on June 23–24, 2025, and is filed under Item 7.01, Regulation FD Disclosure.
Does the Company provide GAAP guidance?
No. The Company states that to the extent it provides guidance, it does so only on a non-GAAP basis and does not provide reconciliations of forward-looking non-GAAP measures to GAAP.
Why doesn't the Company reconcile its guidance to GAAP?
The Company says it cannot predict the amount and timing of impacts outside its control on certain items, such as non-cash gains or losses from mark-to-market adjustments of derivative instruments, which could be material, and reconciling them would require unreasonable efforts.
Is this information considered filed under the Exchange Act?
No. The information in Item 7.01 is not deemed filed for purposes of Section 18 of the Exchange Act and is not subject to that section's liabilities, unless the Company specifically states otherwise or incorporates it by reference into a future filing.
04—Continue